Data / Form D filings / Evecxia, Inc.
Evecxia, Inc.: Form D filings
Evecxia, Inc., a biotechnology company in Research Triangle Park, NC, filed 6 Form D notices with the SEC between 2018 and 2025. The latest, on September 29, 2025, reports $4.6 million sold of a $8 million offering to 97 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2 DAVIS DRIVE, Research Triangle Park, NC, 27709
- Phone
- (919) 597-8762
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1736859
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 29, 2025 | New notice | $8,000,000 | $4,613,213 | $3,386,787 | 97 | Sep 15, 2025 | sec.gov |
| Sep 6, 2023 | New notice | $8,000,000 | $2,438,082 | $5,561,918 | 76 | Aug 22, 2023 | sec.gov |
| Aug 20, 2021 | New notice | $35,000,000 | $8,620,691 | $26,379,309 | 75 | Aug 6, 2021 | sec.gov |
| Sep 11, 2020 | Amendment | $8,500,000 | $7,414,155 | $1,085,845 | 91 | Sep 12, 2019 | sec.gov |
| Sep 17, 2019 | New notice | $6,700,000 | $1,976,092 | $4,723,908 | 14 | Sep 12, 2019 | sec.gov |
| Apr 13, 2018 | New notice | $150,000 | $50,000 | $100,000 | 2 | Apr 5, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jacob Jacobsen | Executive Officer, Director | |
| Elliot Ehrich | Director | |
| Allan Shaw | Director | |
| John Kaiser | Director | |
| Craig Robert Sincock | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Sep 29, 2025 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Evecxia, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.